Search results for: ICH E6 (R3)

Navigating ICH E6(R3): New Standards for Medical Monitoring

Preparing for ICH E6(R3)? Discover how medical monitors can adapt to new safety, compliance, and data integrity standards with advanced monitoring tools.

By |2024-10-31T10:30:22+02:00October 30, 2024|AI in Clinical Trials, Blog, Good Clinical Practice, News|Comments Off on Navigating ICH E6(R3): New Standards for Medical Monitoring

Decoding Sponsor Responsibilities in ICH E6(R3)

Discover the potential impact of the draft ICH E6(R3) guidelines on sponsor responsibilities in clinical trials. Download our free infographic for a comprehensive overview.

By |2024-11-25T19:50:50+02:00May 20, 2024|Good Clinical Practice, News|Comments Off on Decoding Sponsor Responsibilities in ICH E6(R3)

Training Implications of the ICH E6(R3) and E8(R1) Guidelines

Be prepared for ICH E6(R3): turn guidelines into real-world action. In this post, we delve into the key updates and training gaps.

A Comparative Review of the ICH E6(R3) and E8(R1) Guidelines

Unpacking the new ICH guidelines, E6(R3) and E8(R1), we illuminate their key elements, identify gaps, and compare the two in terms of their unity, differences, and complementarity.

By |2024-09-11T16:55:48+02:00May 26, 2023|Blog, Good Clinical Practice, News|Comments Off on A Comparative Review of the ICH E6(R3) and E8(R1) Guidelines

Reflections on ICH E6(R3): Insights from SCOPE Summit 2023

Exciting news on ICH GCP E6(R3) is here! Our CEO, Artem Andrianov, returned from the SCOPE Summit with updates on the updated guideline. ICH E6(R3) will incorporate technology advancements while prioritizing participant protection and reliable evidence. Don't miss Artem's thoughts on his experience at the summit. Stay tuned for more updates on ICH E6(R3)!

By |2024-09-11T16:56:32+02:00February 13, 2023|Blog, Good Clinical Practice, News|Comments Off on Reflections on ICH E6(R3): Insights from SCOPE Summit 2023

Preparing for the Transition to ICH E6 R3 – Key Sponsor Responsibilities

With the ICH E6(R3) guideline set for approval by October 2024, sponsors face new requirements in risk management, RBQM, and data integrity. Stay compliant and efficient by downloading our free infographic that highlights the key differences between ICH E6(R2) and E6(R3).

By |2024-11-25T19:43:54+02:00September 11, 2024|Free Infographics, Good Clinical Practice, News|Comments Off on Preparing for the Transition to ICH E6 R3 – Key Sponsor Responsibilities

Decoding the ICH’s Q9(R1) Quality Risk Management Guideline

Explore the impact of ICH's Q9(R1), Quality Risk Management, guideline on RBQM and clinical trials in our latest blog post. Don't miss our free infographic that simplifies this complex guideline. Enhance your risk strategies today!

By |2024-11-25T17:26:20+02:00December 4, 2023|Blog, Free Infographics, Good Clinical Practice, News|Comments Off on Decoding the ICH’s Q9(R1) Quality Risk Management Guideline

How to Build Critical to Quality Trees for Clinical Research

Building Critical to Quality Trees helps you to translate critical study needs and quality drivers into measurable outcomes and processes. Initially, this Lean Six Sigma approach serves as a business tool based on customer needs. Still, it is a helpful method of implementing Quality by Design in clinical research.

By |2024-11-25T18:15:45+02:00July 29, 2021|Blog|Comments Off on How to Build Critical to Quality Trees for Clinical Research

Empowering Trial Participants: The Right to Access Data and How Sponsors Can Deliver with Ease

Clinical trial participants have the right to access their personal data, a principle emphasized in the ICH E6(R3) guidelines. Sponsors must ensure transparency and provide participants with their data in a clear and accessible format. Our Subject Profiles tool offers a streamlined solution, enabling sponsors to generate comprehensive reports efficiently, thereby meeting regulatory requirements and enhancing participant trust.

By |2024-11-25T15:21:25+02:00November 25, 2024|Blog, Good Clinical Practice, News|Comments Off on Empowering Trial Participants: The Right to Access Data and How Sponsors Can Deliver with Ease
Go to Top